Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dania Therapeutics ApS
APS
Active
Advertising protection
CVR 42523925
Store Kongensgade 77, 1264
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Dania Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-4M
-8M
-12M
-16M
-13M
2022
-10M
+23%
2023
-10M
0%
2024
-4M
+60%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Revenue
0
0
0
0
Staff expenses
-0
-1.240
-1.480
-1.000
EBITDA
-12.859
-10.431
-10.317
-4.390
Depreciation & amort.
-0
-0
-0
-0
EBIT
-12.859
-10.431
-10.317
-4.390
Net financials
298
-291
-1.137
-1.372
Profit before tax
-12.561
-10.722
-11.454
-5.762
Tax
-2.820
-2.000
-1.897
-722
Net profit
-9.741
-8.722
-9.557
-5.040
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
2.990
15.063
7.136
3.502
Equity
2.826
-1.227
-10.373
-15.413
Long-term debt
100
15.611
16.754
18.090
Short-term debt
64
679
755
825
Total debt
164
16.290
17.510
18.915
Financial ratios
5-year trend
EBITDA margin
-439013900.0%
This company
15.8%
Market median
-2778569087% vs market
2022
2025
Equity ratio
-440.1%
This company
38.2%
Market median
-1252% vs market
2022
2025
Return on equity
-503975400.0%
This company
18.4%
Market median
-2738996839% vs market
2022
2025
Net profit margin
-503975400.0%
This company
8.1%
Market median
-6221918619% vs market
2022
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2025
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-12-31
View
PDF
More on Dania Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
